Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · IEX Real-Time Price · USD
0.168
-0.012 (-6.61%)
At close: Apr 23, 2024, 4:00 PM
0.170
+0.002 (1.37%)
After-hours: Apr 23, 2024, 7:59 PM EDT

Jaguar Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Net Income
-41.3-47.45-52.6-38.65-44.73-32.15-21.97-14.73-16.64-9.26
Depreciation & Amortization
2.392.291.812.281.931.320.580.050.010
Share-Based Compensation
2.113.323.972.823.132.030.810.720.990.16
Other Operating Activities
3.568.7411.8413.4313.036.0710.74-0.450.983.09
Operating Cash Flow
-33.24-33.1-34.97-15.28-20.46-22.73-9.82-14.41-14.32-5.36
Capital Expenditures
0-0.08-0.01-0.010-0.010-0.1-0-0.06
Acquisitions
000000-1.56000
Other Investing Activities
--1.6-----2.49-3-
Investing Cash Flow
0-1.68-0.01-0.010-0.01-1.562.38-3-0.06
Share Issuance / Repurchase
33.3420.4633.587.766.6316.6810.38.8318.820
Debt Issued / Paid
-0.952.728.1112.06-0.10.780.38-2.494.520.8
Other Financing Activities
1.84-2.25-0.3315.257.08--1.060.835.28
Financing Cash Flow
34.2323.1843.9419.4921.7724.5510.685.2824.176.07
Exchange Rate Effect
0.020.0200000000
Net Cash Flow
1-11.588.964.211.321.81-0.7-6.756.850.66
Free Cash Flow
-33.24-33.18-34.98-15.29-20.46-22.74-9.82-14.52-14.32-5.41
Free Cash Flow Margin
-340.56%-277.53%-806.83%-162.87%-354.23%-514.87%-225.28%-10258.35%-5541.65%-
Free Cash Flow Per Share
-1.44-25.30-58.67-89.00-927.02-24393.79-53440.27-313203.57-549783.56-448134.99
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).